Pay in 4 interest-free payments of $37.50 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide is a triple agonist targeting the GLP-1
studied for their synergistic potential in tissue repair
🧪 Test Report is available via: Janoshik Test Report
and cellular protection mechanisms
designed to support effortless weight control and improve glucose balance
Retatrutide 40mg Dosage:40mg Retatrutide is a triple agonistRetatrutide is a triple agonist targeting the GLP 1, GIP, and glucagon receptors, designed to support effortless weight control and improve glucose balance. By activating these key metabolic pathways, it recalibrates appetite, enhances energy output, and boosts overall metabolic efficiency for a smoother, more empowered transformation experience. Test Report is available via: Janoshik Test Report
US$ 1449.50
US$ 1225.00
US$ 1425.00
US$ 89.95
US$ 1199.50
US$ 24.95
US$ 1299.50
US$ 50.00
US$ 1225.00
